Loading viewer...
investor_presentation
Format: PDF investor_presentation
Novo Nordisk presents its obesity care strategy and commercial execution plan focused on delivering growth through innovation. The presentation outlines strategic aspirations including obesity sales target of over 25 billion DKK by 2025 and strengthening diabetes market leadership with a goal of capturing more than one-third global value market share.
investor_presentation
13 Pages
Novo Nordisk Full Year 2020 Investor Presentation
investor_presentationinvestor_presentation
130 Pages
Novo Nordisk Full Year 2023 Investor Presentation
investor_presentationinvestor_presentation
163 Pages
investor_presentation
23 Pages
Badger Meter Inc
Dalian Zhongsheng Group Investor Day 2023
investor_presentationinvestor_presentation
61 Pages
Dalian Zhongsheng Group